BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32319567)

  • 1. Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.
    Liu C; Deng S; Jin K; Gong Y; Cheng H; Fan Z; Qian Y; Huang Q; Ni Q; Luo G; Yu X
    Int J Oncol; 2020 Apr; 56(4):900-908. PubMed ID: 32319567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
    Luo G; Liu C; Guo M; Cheng H; Lu Y; Jin K; Liu L; Long J; Xu J; Lu R; Ni Q; Yu X
    Ann Surg; 2017 Apr; 265(4):800-805. PubMed ID: 28267695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathobiological implications of MUC16 expression in pancreatic cancer.
    Haridas D; Chakraborty S; Ponnusamy MP; Lakshmanan I; Rachagani S; Cruz E; Kumar S; Das S; Lele SM; Anderson JM; Wittel UA; Hollingsworth MA; Batra SK
    PLoS One; 2011; 6(10):e26839. PubMed ID: 22066010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
    Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
    Mol Cancer Res; 2017 Feb; 15(2):201-212. PubMed ID: 28108627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
    Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
    Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
    Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
    Coppin L; Benomar K; Corfiotti F; Cattan S; Renaud F; Lapere C; Leteurtre E; Vantyghem MC; Truant S; Pigny P
    Pancreatology; 2016; 16(1):115-20. PubMed ID: 26613889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
    Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.
    Das S; Rachagani S; Torres-Gonzalez MP; Lakshmanan I; Majhi PD; Smith LM; Wagner KU; Batra SK
    Oncotarget; 2015 Mar; 6(8):5772-87. PubMed ID: 25691062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.
    Liang C; Shi S; Meng Q; Liang D; Hua J; Qin Y; Zhang B; Xu J; Ni Q; Yu X
    Int J Cancer; 2018 Dec; 143(11):2919-2931. PubMed ID: 29978477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal colonization by human pancreatic cancer cells is inhibited by antisense FUT3 sequence.
    Aubert M; Panicot-Dubois L; Crotte C; Sbarra V; Lombardo D; Sadoulet MO; Mas E
    Int J Cancer; 2000 Nov; 88(4):558-65. PubMed ID: 11058871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
    Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
    Liu L; Xiang J; Chen R; Fu D; Hong D; Hao J; Li Y; Li J; Li S; Mou Y; Mai G; Ni Q; Peng L; Qin R; Qian H; Shao C; Sun B; Sun Y; Tao M; Tian B; Wang H; Wang J; Wang L; Wang W; Wang W; Zhang J; Zhao G; Zhou J; Yu X;
    Int J Oncol; 2016 Mar; 48(3):900-7. PubMed ID: 26718269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma.
    Jiang K; Tan E; Sayegh Z; Centeno B; Malafa M; Coppola D
    Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):620-623. PubMed ID: 27093451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
    Liu P; Zhu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.